- Reviews (0)
|Applications||FACS IHC IF|
|Antigen/Gene or Protein Targets||CD22|
|Relevance||Establishing origin of B cell malignancies, especially discriminating between immature (bone marrow type) and peripheral B cell leukaemias and lymphomas. Suitable for use as an immunotoxin against human B cell leukaemias and lymphomas.|
|Molecular Weight (kDa)||153|
|Research Area||Adhesion, Cancer, Cell Signaling & Signal Transduction, Immunology, Stem Cell Biology|
Cytoplasmic antigen of mature B lymphocytes. >90% reactivity on peripheral B cells.
Recombinant monoclonal antibody produced from the original monoclonal. Manufactured using Absolute Antibody’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma.
Have you used this reagent? Share your experience by submitting a review and help your fellow scientists.Review this reagent